NCT02359786

Brief Summary

This is a retrospective data collection on treatment of various disorders. This registry will include a variety of different products, implants, technologies and procedures. The registry will also collect any adverse events/complications that occur during or following treatment of these conditions. The data may be utilized to develop strategic treatment pathways and/or benchmarking that will improve patient care. Ultimately, the goal of the registry is to enhance the understanding of healthcare and the treatment in these disease states.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

January 29, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 10, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

February 10, 2015

Status Verified

January 1, 2015

Enrollment Period

5.9 years

First QC Date

January 29, 2015

Last Update Submit

February 4, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • sensory and motor deficits analysis, adverse events, changes in pain, changes in disability, return to work/usual activities, lenttgh of stays, hospital readmission rates, medication compliance rates

    60 months

Study Arms (6)

Genetic Testing Subjects undergoing genetic testing

Topicals Subjects using topical compounds

Patients undergoing Spinal Surgery using IOM

Spine Patients undergoing cervical or lumbar surgery

Total Joint Patients undergoing knee and hip replacement

UDT (unrinary drug test) Patients who are given a UDT

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with various disorders

You may qualify if:

  • Subjects who meet eligibility criteria across 1 of the 6 therapeutic areas

You may not qualify if:

  • Subjects who do not meet eligibility criteria for any of the 6 therapeutic areas

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2015

First Posted

February 10, 2015

Study Start

January 1, 2011

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

February 10, 2015

Record last verified: 2015-01